Baffling the body into accepting transplants

Jan 21, 2009

An unexpected discovery made by a Sydney scientist has potential to alter the body's response to anything it perceives as not 'self', such as a tissue or organ transplant.

Stacey Walters, an immunology researcher at the Garvan Institute of Medical Research, has found that by greatly boosting the levels of the hormone BAFF in mice, it is possible to alter their immune systems so that they will accept tissue transplants without the need for any immunosuppression.

The findings have just been published in the Journal of Immunology.

Specifically, Stacey has found that mice genetically engineered to produce large amounts of BAFF (B cell activating factor), don't reject transplants.

She has shown that increased numbers of B cells (caused by boosted BAFF levels) in turn stimulate the production of T regulatory cells, which then control T cells, the body's killer cells.

The surprising thing about the results is that B cells, which make antibodies, were not known to have any role in the production of T regulatory cells. Nor would it have been thought possible for them to influence the body's response to a transplant, which has been considered a function of T cells only.

"In normal situations, something has to turn the immune system off once your body's fought an invader, such as a virus. It's the T regulatory cells that come in and say 'enough's enough'," Stacey explained.

Just to make sure it was the B cells that were provoking the changes, Stacey repeated her experiments on a mouse in which B cells were genetically knocked out, but high BAFF levels preserved. She found that when there are no B cells, normal allograft rejection occurs.

Stacey's results give us insight into previously unknown interrelationships between various classes of immune cells. Manipulating these relationships may offer a way of preserving organ grafts in the future without the need for toxic immunosuppressive drugs.

Source: Research Australia

Explore further: UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation

add to favorites email to friend print save as pdf

Related Stories

Google launches Internet-beaming balloons

22 hours ago

Wrinkled and skinny at first, the translucent, jellyfish-shaped balloons that Google released this week from a frozen field in the heart of New Zealand's South Island hardened into shiny pumpkins as they ...

Genetic switches play big role in human evolution

Jun 12, 2013

(Phys.org) —A Cornell study offers further proof that the divergence of humans from chimpanzees some 4 million to 6 million years ago was profoundly influenced by mutations to DNA sequences that play roles ...

Scientists discover how rapamycin slows cell growth

May 23, 2013

University of Montreal researchers have discovered a novel molecular mechanism that can potentially slow the progression of some cancers and other diseases of abnormal growth. In the May 23 edition of the prestigious journal ...

Wound healing: 'See-saw' switch sends cells on the march

May 22, 2013

Many genes are transcribed into messenger RNA (mRNA) molecules that provide instructions for protein synthesis. Other genes encode regulatory RNAs known as 'microRNAs', which can block protein translation ...

Recommended for you

Researcher studies protein's link to heart disease

21 hours ago

(Medical Xpress)—The largest protein known to exist in the human body functions as a molecular spring, and University of Arizona researchers are gaining new insights into its role in heart disease.

The rhythm of everything

22 hours ago

Dawn triggers basic biological changes in the waking human body. As the sun rises, so does heart rate, blood pressure and body temperature. The liver, the kidneys and many natural processes also begin shifting ...

User comments : 0

More news stories

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...

3D printing tiny batteries

(Phys.org) —3D printing can now be used to print lithium-ion microbatteries the size of a grain of sand. The printed microbatteries could supply electricity to tiny devices in fields from medicine to communications, ...